LifeStance sees FY22 revenue $845M-$850M, consensus $868.13M

Sees FY22 adjusted EBITDA of $50M-$53M,. The lower guidance ranges relative to prior expectations were primarily driven by lower than expected visit volume and higher than expected costs associated with the company’s employee health benefits program.